Arthrex® AR-2923BCSRecalls & reported problems

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00888867335035), received between Aug 1, 2025 and Feb 18, 2026 — classified as 3 malfunctions.

The most frequently reported specific device problem is “Break” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

• MalfunctionFeb 18, 2026Break

  ON 29-JAN-2026, A SALES REPRESENTATIVE REPORTED VIA EMAIL THAT AN AR-2923BCS SHORT 2.9 MM BIOCOMPOSITE PUSHLOCK IMPLANT SYSTEM EXPERIENCED ANCHOR BREAKAGE DURING INSERTION. THERE WAS NO CASE DELAY, AND IT WAS COMPLETED WITH A REPLACEMENT AR-2923BCS SHORT 2.9 MM BIOCOMPOSITE PUSHLOCK IMPLANT SYSTEM. THIS OCCURRED DURING A LABRAL REPAIR PROCEDURE ON (B)(6) 2026, WITH NO REPORTED PATIENT HARM. ADDITIONAL INFORMATION WAS RECEIVED ON 02-FEB-2026: ALL FRAGMENTS WERE REMOVED FROM THE PATIENT.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 24377462 ↗
• MalfunctionOct 15, 2025Break; Break

  ON 10/06/2025, A SALES REPRESENTATIVE REPORTED VIA EMAIL THAT AN AR-2923BCS BIOCOMPOSITE PUSHLOCK IMPLANT SYSTEM ANCHOR BROKE DURING INSERTION. NO FRAGMENTS WERE RETAINED IN THE PATIENT, AND THE PROCEDURE WAS COMPLETED USING AN AR-2923BC BIOCOMPOSITE PUSHLOCK SUTURE ANCHOR WITHOUT FURTHER ISSUES. THIS WAS DISCOVERED DURING A LABRAL REPAIR PROCEDURE ON (B)(6) 2025, WITH NO REPORTED PATIENT HARM. ADDITIONAL INFORMATION WAS RECEIVED ON 10/10/2025: AR-2923BCS BIOCOMPOSITE PUSHLOCK IMPLANT SYSTEM ANCHOR BROKE INTO PIECES DURING INSERTION. THE BONE QUALITY WAS ASSESSED AS HARD. THERE WAS NO SIGNIFICANT DELAY, NO ADDITIONAL ANESTHESIA WAS ADMINISTERED, AND NO ADVERSE EFFECTS WERE NOTED. NO PHOTOGRAPHS WERE TAKEN TO DOCUMENT THE EVENT.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 23302601 ↗
• MalfunctionAug 1, 2025Break; Break

  ON 07/10/2025, A SALES REPRESENTATIVE REPORTED VIA EMAIL THAT AN AR-2923BCS BIOCOMPOSITE PUSHLOCK IMPLANT SYSTEM EXPERIENCED A FAILURE DURING A PROCEDURE ON (B)(6) 2025. SPECIFICALLY, THE PUSHLOCK EYELET BROKE AFTER THE DRILL WAS USED AND CYCLED. NO PATIENT HARM WAS REPORTED. ADDITIONAL INFORMATION HAS BEEN REQUESTED ON 07/16/2025.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22687055 ↗